Buradasınız

Uzun süreli antiepileptik ilaç tedavisinin beyinsapı işitsel uyarılmış potansiyelleri üzerine olan etkisi ve klinik önemi

Effects of long-term antiepileptic drug therapy on brainstem auditory evoked potentials in epileptic patients and its clinical importance

Journal Name:

Publication Year:

Abstract (2. Language): 
Results of the studies investigating the effects of antiepileptic drugs on auditory evoked potentials are contradictory. We, thus in this study, aimed to investigate the effects of long-term antiepileptic drug therapy on brainstem auditory evoked potentials in children with idiopathic epilepsia and to discuss its clinical importance. Fifty one children followed-up with the diagnosis of idiopathic epilepsia and receiving either valproic acid or carbamazepine for at least 6 months were enrolled in the study. The two study groups consisted of 35 patients using valproic acid (17 male and 18 female) and 16 patients using carbamazepine (7 male and 9 female). A control group including thirty three healthy children (17 male, 16 female) with a similar age and gender distribution was constituted. The age, gender, the dose and duration of treatment of the antiepileptic drug used and results of the auditory evoked potentials in all cases were recorded. Waves I, III and V, and interpeak latencies I-III and I-V of the study groups were significantly prolonged as compared with the control group (p<0.05). However, there were no significant differences among the groups with respect to wave I and interpeak latency III-V (p>0.05). In conclusion we demonstrated in this study that long-term antiepileptic drug therapy caused prolongation of auditory evoked potentials in epileptic patients. These results show that brainstem auditory evoked potentials are a sensitive and noninvasive test that may be used in demonstrating the adverse effects of long-term antiepileptic drug therapy on central nervous system.
Abstract (Original Language): 
Antiepileptik ilaçların beyinsapı işitsel uyarılmış potansiyelleri üzerine olan etkileri ile ilgili çalışmaların sonuçları birbirleri ile çelişmektedir. Biz de bu çalışmada idiyopatik epilepsili çocuk hastalarda uzun süreli antiepileptik ilaç tedavisinin beyinsapı işitsel uyarılmış potansiyelleri üzerine olan etkilerini ve bu etkilerin klinik önemini tartışmayı amaçladık. Çalışmaya idiyopatik epilepsi tanısıyla takip edilmekte olup en az 6 aydır karbamazepin veya valproik asid kullanmakta olan 51 çocuk hasta kabul edildi. Çalışma grupları 35'i valproik asid (17 erkek, 18 kız) ve 16'sı karbamazepin (7 erkek, 9 kız) kullanmakta olan hastalardan oluşturuldu. Kontrol grubu benzer yaş ve cinsiyetteki 33 sağlıklı çocuktan (17 erkek, 16 kız) oluşturuldu. Hastaların yaş, cinsiyet, kullandıkları antiepileptik ilaç ve dozları, tedavi süreleri ve beyinsapı işitsel uyarılmış potansiyelleri sonuçları kaydedildi. Çalışma gruplarının dalga I, III, V ve IIII, I-V interpik latans değerleri kontrol grubuna göre anlamlı düzeyde uzamış olarak saptandı (p<0.05). Ancak dalga I ve III-V interpik latans değerleri bakımından gruplar arasında anlamlı bir farklılık saptanmadı (p>0.05). Sonuç olarak bu çalışmada epileptik hastalarda uzun süreli antiepileptik ilaç tedavisinin beyinsapı işitsel uyarılmış potansiyellerinde uzamaya neden olduğunu saptadık. Bu sonuçlar göstermiştir ki beyinsapı işitsel uyarılmış potansiyelleri uzun süreli antiepileptik tedavisinin santral sinir sistemi üzerine olan yan etkilerini göstermekte kullanılabilecek, duyarlı ve invaziv olmayan bir testtir.
5-8

REFERENCES

References: 

1. Nekrassov V, Sitges M. Additive effects of antiepileptic
drugs and pentylenetetrazole on hearing. Neurosci Lett
2006; 406: 276-280.
2. Verrotti A, Trotta D, Cutarella R, Pascarella R, Morgese
G, Chiarelli F. Effects of antiepileptic drugs on evoked
potentials in epileptic children. Pediatr Neurol 2000; 23:
397-402.
3. Sitges M, Nekrassov V. Acute and chronic effects of carbamazepine, phenytoin, valproate and vinpocetine on
BAEP parameters and threshold in the guinea pig. Clin
Neurophysiol 2007; 118: 420-426.
4. Sundqvist A, Nilsson BY, Tomson T. Valproate
monotherapy in juvenile myoclonic epilepsy: dose-related
effects on electroencephalographic and other neurophysiologic tests. Ther Drug Monit 1999; 21: 91-96.
5. Panagopoulos GR, Thomaides T, Tagaris G,
Karageorgiou CL. Auditory event related potentials in
patients with epilepsy on sodium valproate monotherapy.
Acta Neurol Scand 1997; 96: 62-64.
6. Enoki H, Sanada S, Oka E, Ohtahara S. Effects of highdose antiepileptic drugs on event-related potentials in
epileptic children. Epilepsy Res 1996; 25: 59-64.
7. Yüksel A, Sarslan O, Devranoðlu K, et al. Effect of valproate and carbamazepine on visual evoked potentials in
epileptic children. Acta Paediatr Jpn 1995; 37: 358-361.
8. Jewett DL, Romano MN, Williston JS. Human auditory
evoked potentials: possible brain stem components
detected on the scalp. Science 1970; 167: 1517-1518.
9. Zgorzalewicz M. Bimodal evoked potentials during longterm therapy with conventional or slow release preparations of carbamazepine and valproic acid in children and
adolescents with epilepsy. Neurol Neurochir Pol 2000; 34
(Suppl 1): 119-128.
10. Garcia Alvarez F, Al-Ghanem R, Cortes BM, Cabrero
LC. The application of evoked potentials to evaluative
control of continuous spike/wave epilepsy during slow
wave sleep. Neurologia 1993; 8: 177-179.
11. Mervaala E, Keranen T, Penttila M, Partanen JV,
Rjekkinen P. Pattern reversal VEP and cortical SEP latency prolongation in epilepsy. Epilepsia 1985; 26: 441-445.
12. Møller AR, Jannetta PJ. Evoked potentials from the inferior colliculus in man. Electroencephalogr Clin
Neurophysiol 1982; 53: 612-620.
13. Yuksel A, Senocak D, Sozuer D, et al. Effects of carbamazepine and valproate on brainstem auditory evoked
potentials in epileptic children. Childs Nerv Syst 1995;
11: 474-477.
14. Erdem H, Yiðit A, Culcuoðlu A, Mutluer N. Effect of
sodium valproate on somatosensory evoked potentials in
juvenile myoclonic epilepsy. Ups J Med Sci 2001; 106:
197-203.
15.Burkard R, Feldman M, Voigt HF. Brainstem auditoryevoked response in the rat. Normative studies, with
observations concerning the effects of ossicular disruption. Audiology 1990; 29: 146-162.
16.Armon E, Brown S, Carwile P, Miller CS. Sensorineural
hearing loss: a reversible effect of valproic acid.
Neurology 1990; 40: 1896-1898.
17. Chen YJ, Kang WM, So WC. Comparison of antiepileptic
drugs on cognitive function in newly diagnosed epileptic
children: a psychometric and neurophysiological study.
Epilepsia 1996; 37: 81-86.

Thank you for copying data from http://www.arastirmax.com